Skip to content
  • About
  • Contact
  • Contribute
  • Book
  • Careers
  • Podcast
  • Recommended
  • Speaking
  • All
  • Physician
  • Practice
  • Policy
  • Finance
  • Conditions
  • .edu
  • Patient
  • Meds
  • Tech
  • Social
  • Video
    • All
    • Physician
    • Practice
    • Policy
    • Finance
    • Conditions
    • .edu
    • Patient
    • Meds
    • Tech
    • Social
    • Video
    • About
    • Contact
    • Contribute
    • Book
    • Careers
    • Podcast
    • Recommended
    • Speaking

Doing no harm to addicts might be doing a lot of harm

Sarah Fraser, MD
Physician
June 2, 2017
Share
Tweet
Share

“Do no harm.”

This is a key phrase in the Hippocratic Oath; one that I announced with conviction at my medical school graduation. I swear to do no harm. What would Hippocrates, the Father of Modern Medicine, think about the concept of harm reduction?

Canada has a drug problem. We are one of the world’s largest per-capita opioid consumers. The country is facing what has become known in the media as the “opioid epidemic.” The government of British Columbia declared a public health emergency in response to the increasing number of overdoses from opioids. A total of 914 people died from illicit substance overdose in 2016 in the province, representing an 80 percent increase from the previous year.

While recently traveling in Vancouver, I rode my bicycle through the Downtown Eastside. Users were injecting on the street in broad daylight; drug deals were being done openly. The crisis is alive and well where I work as a family physician on the East Coast, too.

The traditional approach in treating drug addiction was sending users to rehab for detoxification, the goal being to get “clean” while providing strategies to prevent relapse. Often, such programming was based on abstinence (cutting drug use out completely). However, the most recent literature shows that when it comes to treating opioid addiction, harm reduction is a superior method.

In Canada, the CAMH (Centre for Addiction and Mental Health) defines harm reduction as “any policy or program designed to reduce drug-related harm without requiring the cessation of drug use.” One example of harm reduction is opioid substitution therapy (OST), using drugs like methadone and buprenorphine to treat opioid dependence.

Normally, opioids like heroin or fentanyl work by binding to receptors in the brain that cause intense feelings of euphoria and pain relief. Drugs like methadone and buprenorphine bind to those same receptors but don’t produce euphoria. They help to prevent withdrawal without making the person high.

The research in support of opioid substitution therapy is clear: it works, and it’s more effective than abstinence-based programming. Patients taking OST are more likely to stay in their treatment programs and are less likely to use illicit drugs. OST reduces the chances of contracting diseases like Hepatitis C and HIV. Most importantly, OST patients are less likely to overdose.

With abstinence-based programming, patients are at higher risk for overdose upon getting out of rehab. This is because their tolerance is typically much lower than when they were first admitted. If they relapse once discharged, they may try to consume the same amount of the drug as they had in the past. The consequences are often lethal.

In addition to saving lives, opioid substitution therapy has financial benefits. Reducing the rates of HIV, for example, decreases the costs associated with treating the disease. Some studies have also shown that OST helps reduce criminal activity, another way to save the system money.

In other words, harm reduction works. Yet, it is still questioned by government officials, members of the public and even health care professionals. With such strong evidence in favor of harm reduction, why is there still so much resistance?

So much of what we do in medicine is harm reduction. I do not expect my diabetic patients to eliminate all unhealthy foods. Instead, the goal is to reduce their risk of complications from having high sugars. If the sugars come down, it is a cause for celebration. But when a person who has recently enrolled in a methadone program has two overdoses per year instead of four, success is not the obvious deduction. We don’t blame a person for succumbing to the temptation of a pastry in the same way an addict is judged for shooting up.

Addiction needs to be seen as the life-threatening, chronic, relapsing disease that it is. To stigmatize those living with it is to cause harm. To dispute evidence-based medicine is to cause harm. If Hippocrates were alive today, I think he would agree with a slight modification to his long-lasting oath.

Let’s do less harm.

ADVERTISEMENT

Sarah Fraser is a general practitioner who blogs at Sinus Rhythm.

Image credit: Shutterstock.com 

Prev

Here's the place where burned out physicians go

June 2, 2017 Kevin 0
…
Next

Why it's hard for physicians to order fewer tests

June 2, 2017 Kevin 7
…

Tagged as: Patients

Post navigation

< Previous Post
Here's the place where burned out physicians go
Next Post >
Why it's hard for physicians to order fewer tests

ADVERTISEMENT

More by Sarah Fraser, MD

  • These 2 Canadian provinces are getting it right in the COVID-19 pandemic

    Sarah Fraser, MD
  • The bittersweet post-COVID life for this physician

    Sarah Fraser, MD
  • How long does coronavirus stay on surfaces?

    Sarah Fraser, MD

Related Posts

  • Why social media may be causing real emotional harm

    Edwin Leap, MD
  • Making America great again with harm reduction

    Mark Leeds, DO
  • Don’t let fear harm your health

    Michele Luckenbaugh
  • Protect and serve. Do no harm. Both are failing.

    Jayshree Chander, MD, MPH
  • A physician’s addiction to social media

    Amanda Xi, MD
  • I graduated medical school while sitting in the parking lot

    Gregory Stimac

More in Physician

  • How functional medicine fills the gaps left by conventional care

    Sally Daganzo, MD
  • A step‑by‑step guide to crafting meaningful research questions

    Julian Gendreau, MD
  • How restrictive opioid policies worsen the crisis

    Kayvan Haddadan, MD
  • The dying man who gave me flowers changed how I see care

    Augusta Uwah, MD
  • How market forces fracture millennial physicians’ careers

    Shannon Meron, MD
  • Unity in primary care: Why I believe physicians and NPs/PAs must work together toward the same goal

    Jerina Gani, MD, MPH
  • Most Popular

  • Past Week

    • Could antibiotics beat heart disease where statins failed?

      Larry Kaskel, MD | Conditions
    • How restrictive opioid policies worsen the crisis

      Kayvan Haddadan, MD | Physician
    • Why palliative care is more than just end-of-life support

      Dr. Vishal Parackal | Conditions
    • When life makes you depend on Depends

      Francisco M. Torres, MD | Physician
    • Guilty until proven innocent? My experience with a state medical board.

      Jeffrey Hatef, Jr., MD | Physician
    • Why medical notes have become billing scripts instead of patient stories

      Sriman Swarup, MD, MBA | Tech
  • Past 6 Months

    • Why transgender health care needs urgent reform and inclusive practices

      Angela Rodriguez, MD | Conditions
    • COVID-19 was real: a doctor’s frontline account

      Randall S. Fong, MD | Conditions
    • Why primary care doctors are drowning in debt despite saving lives

      John Wei, MD | Physician
    • New student loan caps could shut low-income students out of medicine

      Tom Phan, MD | Physician
    • Why pain doctors face unfair scrutiny and harsh penalties in California

      Kayvan Haddadan, MD | Physician
    • mRNA post vaccination syndrome: Is it real?

      Harry Oken, MD | Conditions
  • Recent Posts

    • How functional medicine fills the gaps left by conventional care

      Sally Daganzo, MD | Physician
    • A psychiatrist’s 20-year journey with ketamine

      Muhamad Aly Rifai, MD | Meds
    • How racism and policy failures shape reproductive health in America

      Kaitlynn Esemaya, Alexis Thompson, Annique McLune, and Anamaria Ancheta | Education
    • Why GLP‑1 drugs should be covered beyond weight loss

      Rodney Lenfant | Conditions
    • How drug companies profit by inventing diseases

      Martha Rosenberg | Meds
    • How value-based care reshapes kidney disease management for better outcomes [PODCAST]

      The Podcast by KevinMD | Podcast

Subscribe to KevinMD and never miss a story!

Get free updates delivered free to your inbox.


Find jobs at
Careers by KevinMD.com

Search thousands of physician, PA, NP, and CRNA jobs now.

Learn more

View 1 Comments >

Founded in 2004 by Kevin Pho, MD, KevinMD.com is the web’s leading platform where physicians, advanced practitioners, nurses, medical students, and patients share their insight and tell their stories.

Social

  • Like on Facebook
  • Follow on Twitter
  • Connect on Linkedin
  • Subscribe on Youtube
  • Instagram

ADVERTISEMENT

ADVERTISEMENT

  • Most Popular

  • Past Week

    • Could antibiotics beat heart disease where statins failed?

      Larry Kaskel, MD | Conditions
    • How restrictive opioid policies worsen the crisis

      Kayvan Haddadan, MD | Physician
    • Why palliative care is more than just end-of-life support

      Dr. Vishal Parackal | Conditions
    • When life makes you depend on Depends

      Francisco M. Torres, MD | Physician
    • Guilty until proven innocent? My experience with a state medical board.

      Jeffrey Hatef, Jr., MD | Physician
    • Why medical notes have become billing scripts instead of patient stories

      Sriman Swarup, MD, MBA | Tech
  • Past 6 Months

    • Why transgender health care needs urgent reform and inclusive practices

      Angela Rodriguez, MD | Conditions
    • COVID-19 was real: a doctor’s frontline account

      Randall S. Fong, MD | Conditions
    • Why primary care doctors are drowning in debt despite saving lives

      John Wei, MD | Physician
    • New student loan caps could shut low-income students out of medicine

      Tom Phan, MD | Physician
    • Why pain doctors face unfair scrutiny and harsh penalties in California

      Kayvan Haddadan, MD | Physician
    • mRNA post vaccination syndrome: Is it real?

      Harry Oken, MD | Conditions
  • Recent Posts

    • How functional medicine fills the gaps left by conventional care

      Sally Daganzo, MD | Physician
    • A psychiatrist’s 20-year journey with ketamine

      Muhamad Aly Rifai, MD | Meds
    • How racism and policy failures shape reproductive health in America

      Kaitlynn Esemaya, Alexis Thompson, Annique McLune, and Anamaria Ancheta | Education
    • Why GLP‑1 drugs should be covered beyond weight loss

      Rodney Lenfant | Conditions
    • How drug companies profit by inventing diseases

      Martha Rosenberg | Meds
    • How value-based care reshapes kidney disease management for better outcomes [PODCAST]

      The Podcast by KevinMD | Podcast

MedPage Today Professional

An Everyday Health Property Medpage Today
  • Terms of Use | Disclaimer
  • Privacy Policy
  • DMCA Policy
All Content © KevinMD, LLC
Site by Outthink Group

Doing no harm to addicts might be doing a lot of harm
1 comments

Comments are moderated before they are published. Please read the comment policy.

Loading Comments...